Hale John E
Hale Biochemical Consulting, 6341 Wyatt Lane, Klamath Falls, OR 97601, USA.
Int J Proteomics. 2013;2013:219452. doi: 10.1155/2013/219452. Epub 2013 Jan 8.
Quantitative protein measurements by mass spectrometry have gained wide acceptance in research settings. However, clinical uptake of mass spectrometric protein assays has not followed suit. In part, this is due to the long-standing acceptance by regulatory agencies of immunological assays such as ELISA assays. In most cases, ELISAs provide highly accurate, sensitive, relatively inexpensive, and simple assays for many analytes. The barrier to acceptance of mass spectrometry in these situations will remain high. However, mass spectrometry provides solutions to certain protein measurements that are difficult, if not impossible, to accomplish by immunological methods. Cases where mass spectrometry can provide solutions to difficult assay development include distinguishing between very closely related protein species and monitoring biological and analytical variability due to sample handling and very high multiplexing capacity. This paper will highlight several examples where mass spectrometry has made certain protein measurements possible where immunological techniques have had a great difficulty.
通过质谱进行的蛋白质定量测量在研究领域已获得广泛认可。然而,质谱蛋白质分析在临床中的应用却未能跟上步伐。部分原因在于监管机构长期以来对免疫分析方法(如酶联免疫吸附测定法)的认可。在大多数情况下,酶联免疫吸附测定法为许多分析物提供了高度准确、灵敏、相对廉价且操作简单的检测方法。在这些情况下,质谱分析被接受的障碍仍然很高。然而,质谱分析为某些蛋白质测量提供了解决方案,而这些测量即便不是不可能,通过免疫方法也很难完成。质谱分析能够为难以进行的检测开发提供解决方案的情况包括区分非常相近的蛋白质种类,以及监测由于样品处理导致的生物学和分析变异性,还有其极高的多重检测能力。本文将重点介绍几个例子,说明质谱分析在免疫技术面临巨大困难的情况下,如何实现了某些蛋白质测量。